Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017 (2017), Article ID 8468469, 14 pages
https://doi.org/10.1155/2017/8468469
Research Article

Declining Physical Performance Associates with Serum FasL, miR-21, and miR-146a in Aging Sprinters

1Gerontology Research Center, Department of Health Sciences, University of Jyvaskyla, Jyvaskyla, Finland
2Department of Medical Rehabilitation, Oulu University Hospital, Oulu, Finland
3Center for Life Course Health Research, University of Oulu, Oulu, Finland

Correspondence should be addressed to Reeta Kangas; if.uyj@sagnak.s.m.ateer

Received 22 April 2016; Revised 2 November 2016; Accepted 21 November 2016; Published 3 January 2017

Academic Editor: David C. Hughes

Copyright © 2017 Reeta Kangas et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Ostrowski, P. Schjerling, and B. K. Pedersen, “Physical activity and plasma interleukin-6 in humans—effect of intensity of exercise,” European Journal of Applied Physiology, vol. 83, no. 6, pp. 512–515, 2000. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Gleeson, N. C. Bishop, D. J. Stensel, M. R. Lindley, S. S. Mastana, and M. A. Nimmo, “The anti-inflammatory effects of exercise: mechanisms and implications for the prevention and treatment of disease,” Nature Reviews Immunology, vol. 11, no. 9, pp. 607–615, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. U. R. Mikkelsen, C. Couppé, A. Karlsen et al., “Life-long endurance exercise in humans: circulating levels of inflammatory markers and leg muscle size,” Mechanisms of Ageing and Development, vol. 134, no. 11-12, pp. 531–540, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. T. A. W. Paulson, V. L. Goosey-Tolfrey, C. A. Leicht, and N. C. Bishop, “Plasma cytokine and exertional responses in relation to exercise intensity and volume of exercising muscle mass during arm-crank ergometry,” Applied Physiology, Nutrition and Metabolism, vol. 40, no. 8, pp. 782–787, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Penkowa, C. Keller, P. Keller, S. Jauffred, and B. K. Pedersen, “Immunohistochemical detection of interleukin-6 in human skeletal muscle fibers following exercise,” The FASEB Journal, vol. 17, no. 14, pp. 2166–2168, 2003. View at Google Scholar · View at Scopus
  6. M. Ozdemirli, M. El-Khatib, L. C. Foote et al., “Fas (CD95)/Fas ligand interactions regulate antigen-specific, major histocompatibility complex-restricted T/B cell proliferative responses,” European Journal of Immunology, vol. 26, no. 2, pp. 415–419, 1996. View at Publisher · View at Google Scholar · View at Scopus
  7. F. C. Mooren, A. Lechtermann, and K. Völker, “Exercise-induced apoptosis of lymphocytes depends on training status,” Medicine and Science in Sports and Exercise, vol. 36, no. 9, pp. 1476–1483, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. H. Valadi, K. Ekström, A. Bossios, M. Sjöstrand, J. J. Lee, and J. O. Lötvall, “Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells,” Nature Cell Biology, vol. 9, no. 6, pp. 654–659, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. C. C. Pritchard, E. Kroh, B. Wood et al., “Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies,” Cancer Prevention Research, vol. 5, no. 3, pp. 492–497, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. F. Olivieri, L. Spazzafumo, G. Santini et al., “Age-related differences in the expression of circulating microRNAs: miR-21 as a new circulating marker of inflammaging,” Mechanisms of Ageing and Development, vol. 133, no. 11-12, pp. 675–685, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Park, X. Huang, C. Lu, M. S. Cairo, and X. Zhou, “MicroRNA-146a and microRNA-146b regulate human dendritic cell apoptosis and cytokine production by targeting TRAF6 and IRAK1 proteins,” Journal of Biological Chemistry, vol. 290, no. 5, pp. 2831–2841, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. G. Curtale, F. Citarella, C. Carissimi et al., “An emerging player in the adaptive immune response: microRNA-146a is a modulator of IL-2 expression and activation-induced cell death in T lymphocytes,” Blood, vol. 115, no. 2, pp. 265–273, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. D. Sayed, M. He, C. Hong et al., “MicroRNA-21 is a downstream effector of AKT that mediates its antiapoptotic effects via suppression of fas ligand,” Journal of Biological Chemistry, vol. 285, no. 26, pp. 20281–20290, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. W. A. He, F. Calore, P. Londhe, A. Canella, D. C. Guttridge, and C. M. Croce, “Microvesicles containing miRNAs promote muscle cell death in cancer cachexia via TLR7,” Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 12, pp. 4525–4529, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. A. L. Baggish, A. Hale, R. B. Weiner et al., “Dynamic regulation of circulating microRNA during acute exhaustive exercise and sustained aerobic exercise training,” Journal of Physiology, vol. 589, no. 16, pp. 3983–3994, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. W. Aoi, H. Ichikawa, K. Mune et al., “Muscle-enriched micro RNA miR-486 decreases in circulation in response to exercise in young men,” Frontiers in Physiology, vol. 4, article 80, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Nielsen, T. Åkerström, A. Rinnov et al., “The miRNA plasma signature in response to acute aerobic exercise and endurance training,” PLoS ONE, vol. 9, no. 2, Article ID e87308, 2014. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Bye, H. Røsjø, S. T. Aspenes, G. Condorelli, T. Omland, and U. Wisløff, “Circulating microRNAs and aerobic fitness—The HUNT-Study,” PLOS ONE, vol. 8, no. 2, Article ID e57496, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. S. L. Wardle, M. E. S. Bailey, A. Kilikevicius et al., “Plasma microRNA levels differ between endurance and strength athletes,” PLOS ONE, vol. 10, no. 4, Article ID e0122107, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Nielsen, T. Hvid, M. Kelly et al., “Muscle specific miRNAs are induced by testosterone and independently upregulated by age,” Frontiers in Physiology, vol. 4, article 394, 2014. View at Publisher · View at Google Scholar · View at Scopus
  21. M. T. Korhonen, A. Mero, and H. Suominen, “Age-related differences in 100-M sprint performance in male and female master runners,” Medicine and Science in Sports and Exercise, vol. 35, no. 8, pp. 1419–1428, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. M. T. Korhonen, A. Cristea, M. Alén et al., “Aging, muscle fiber type, and contractile function in sprint-trained athletes,” Journal of Applied Physiology, vol. 101, no. 3, pp. 906–917, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. A. Cristea, M. T. Korhonen, K. Häkkinen et al., “Effects of combined strength and sprint training on regulation of muscle contraction at the whole-muscle and single-fibre levels in elite master sprinters,” Acta Physiologica, vol. 193, no. 3, pp. 275–289, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. M. T. Korhonen, A. A. Mero, M. AlIn et al., “Biomechanical and skeletal muscle determinants of maximum running speed with aging,” Medicine & Science in Sports & Exercise, vol. 41, no. 4, pp. 844–856, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. M. T. Korhonen, A. Heinonen, J. Siekkinen et al., “Bone density, structure and strength, and their determinants in aging sprint athletes,” Medicine and Science in Sports and Exercise, vol. 44, no. 12, pp. 2340–2349, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. R. Kangas, E. Pöllänen, M. R. Rippo et al., “Circulating miR-21, miR-146a and Fas ligand respond to postmenopausal estrogen-based hormone replacement therapy—a study with monozygotic twin pairs,” Mechanisms of Ageing and Development, vol. 143-144, pp. 1–8, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. L. A. Schaap, S. M. F. Pluijm, D. J. H. Deeg et al., “Higher inflammatory marker levels in older persons: associations with 5-year change in muscle mass and muscle strength,” Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, vol. 64, no. 11, pp. 1183–1189, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. C. Franceschi, M. Bonafè, S. Valensin et al., “Inflamm-aging. An evolutionary perspective on immunosenescence,” Annals of the New York Academy of Sciences, vol. 908, pp. 244–254, 2000. View at Google Scholar · View at Scopus
  29. N. Kavathia, A. Jain, J. Walston, B. A. Beamer, and N. S. Fedarko, “Serum markers of apoptosis decrease with age and cancer stage,” Aging, vol. 1, no. 7, pp. 652–663, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. T. Ichikura, T. Majima, T. Uchida, E. Okura, T. Ogawa, and H. Mochizuki, “Plasma soluble Fas ligand concentration: decrease in elderly men and increase in patients with gastric carcinoma,” Oncology Reports, vol. 8, no. 2, pp. 311–314, 2001. View at Google Scholar · View at Scopus
  31. M. Tanaka, T. Suda, K. Haze et al., “Fas ligand in human serum,” Nature Medicine, vol. 2, no. 3, pp. 317–322, 1996. View at Google Scholar
  32. K. Nozawa, N. Kayagaki, Y. Tokano, H. Yagita, K. Okumura, and H. Hasimoto, “Soluble Fas (APO-1, CD95) and soluble Fas ligand in rheumatic diseases,” Arthritis and Rheumatism, vol. 40, no. 6, pp. 1126–1129, 1997. View at Publisher · View at Google Scholar · View at Scopus
  33. M. C. Turi, M. D'Urbano, E. Celletti, C. Alessandri, G. Valesini, and R. Paganelli, “Serum sFas/sFasL ratio in systemic lupus erythematosus (SLE) is a function of age,” Archives of Gerontology and Geriatrics, vol. 49, supplement 1, pp. 221–226, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Tower, “Programmed cell death in aging,” Ageing Research Reviews, vol. 23, pp. 90–100, 2015. View at Publisher · View at Google Scholar · View at Scopus
  35. H. R. Jones, C. T. Robb, M. Perretti, and A. G. Rossi, “The role of neutrophils in inflammation resolution,” Seminars in Immunology, vol. 28, no. 2, pp. 137–145, 2016. View at Publisher · View at Google Scholar
  36. B. G. Vopat, S. A. Klinge, P. K. McClure, and P. D. Fadale, “The effects of fitness on the aging process,” Journal of the American Academy of Orthopaedic Surgeons, vol. 22, no. 9, pp. 576–585, 2014. View at Publisher · View at Google Scholar · View at Scopus
  37. N. R. Lazarus and S. D. R. Harridge, “Inherent ageing in humans: the case for studying master athletes,” Scandinavian Journal of Medicine and Science in Sports, vol. 17, no. 5, pp. 461–463, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Sawada, M. Kon, S. Wada, T. Ushida, K. Suzuki, and T. Akimoto, “Profiling of circulating microRNAs after a bout of acute resistance exercise in humans,” PLOS ONE, vol. 8, no. 7, Article ID e70823, 2013. View at Publisher · View at Google Scholar · View at Scopus